Are you or any of your colleagues attending EASL in Milan this week? Quantify is on site and happy to connect!

Two Quantify abstracts have been selected for poster presentation and for oral presentation in the Abstract session – “MASLD: Clinical aspects”.
The presentations include the first results from the REVEAL-MASH study conducted by Quantify’s Emilie Toresson Grip and Helena Skröder Löveborn in ongoing collaboration with Karolinska Institutet and Novo Nordisk. Emilie Toresson Grip will present the findings at prime-time Friday morning in Room Space 1+2 – don’t miss out!

Oral OS – 052: “Characteristics and risk of major adverse liver outcomes & major cardiovascular events among swedish patients with diagnosed and high risk of metabolic dysfunction-associated steatohepatitis – a REVEAL-MASH study”
Friday, 07/06/2024, 8.30am, Space 1+2

Poster FRI – 201 : “Health care resource utilization for patients diagnosed and at high risk of metabolic dysfunction-associated steatohepatitis in Stockholm, Sweden – a REVEAL-MASH study”
Friday, 07/06/2024